Jonathan S. Zager, MD, on Results of Phase 3 FOCUS Trial Examining Percutaneous Hepatic Perfusion in Ocular Melanoma With Hepatic Metastases
Jonathan S. Zager, MD, discussed the use of percutaneous hepatic perfusion vs best alternative care for patients with hepatic-dominant ocular melanoma analyzed in the phase 3 FOCUS trial.
POINT: Surgical Management of Lymph Node Basin in Sentinel Lymph Node–Positive Melanoma
CLND as standard of care for patients with SLN-positive metastatic melanoma is supported by a wealth of compelling prospective data.